Literature DB >> 29975211

Choosing Between Daily and Event-Driven Pre-exposure Prophylaxis: Results of a Belgian PrEP Demonstration Project.

Thijs Reyniers1, Christiana Nöstlinger1,2, Marie Laga1, Irith De Baetselier3, Tania Crucitti3, Kristien Wouters3, Bart Smekens3, Jozefien Buyze3, Bea Vuylsteke1.   

Abstract

BACKGROUND: Daily pre-exposure prophylaxis and event-driven pre-exposure prophylaxis (PrEP) are efficacious in reducing HIV transmission among men who have sex with men (MSM). We analyzed baseline data from a PrEP demonstration project "Be-PrEP-ared" in Antwerp, Belgium, to understand preferences for daily PrEP or event-driven PrEP among MSM at high risk of HIV and factors influencing their initial choice.
METHODS: Cross-sectional data from an open-label prospective cohort study, using mixed methods. Participants who preregistered online were screened for eligibility and tested for sexually transmitted infections (STIs). Eligible participants chose between daily PrEP and event-driven PrEP and reported on behavioral data through an electronic questionnaire. In-depth interviews were conducted with a selected subsample. Bivariate associations were examined between preferred PrEP regimens and sociodemographic factors, sexual behavior, and STIs at screening.
RESULTS: In total, 200 participants were enrolled between October 2015 and December 2016. Self-reported levels of sexual risk-taking before enrollment were high. STI screening revealed that 39.5% had at least 1 bacterial STI. At baseline, 76.5% of participants preferred daily PrEP and 23.5% event-driven PrEP. Feeling able to anticipate HIV risk was the most frequent reason for preferring event-driven PrEP. Regimen choice was associated with sexual risk-taking behavior in the past 3 months. Almost all participants (95.7%) considered it likely that they would change their dosing regimen the following year.
CONCLUSION: Event-driven PrEP was preferred by 23.5% of the participants, which better suits their preventive needs. Event-driven PrEP should be included in PrEP provision as a valuable alternative to daily PrEP for MSM at high risk of HIV.

Entities:  

Mesh:

Year:  2018        PMID: 29975211     DOI: 10.1097/QAI.0000000000001791

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  23 in total

Review 1.  Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation.

Authors:  Victoria E Powell; Kevin M Gibas; Joshua DuBow; Douglas S Krakower
Journal:  Curr Infect Dis Rep       Date:  2019-06-21       Impact factor: 3.725

2.  Awareness of, Willingness to Take PrEP and Its Actual Use Among Belgian MSM at High Risk of HIV Infection: Secondary Analysis of the Belgian European MSM Internet Survey.

Authors:  Veerle Buffel; Thijs Reyniers; Caroline Masquillier; Estrelle Thunissen; Christiana Nöstlinger; Marie Laga; Edwin Wouters; Wim Vanden Berghe; Jessika Deblonde; Bea Vuylsteke
Journal:  AIDS Behav       Date:  2021-11-24

3.  Switching to Non-daily Pre-exposure Prophylaxis Among Gay and Bisexual Men in Australia: Implications for Improving Knowledge, Safety, and Uptake.

Authors:  Steven P Philpot; Dean Murphy; Curtis Chan; Bridget Haire; Doug Fraser; Andrew E Grulich; Benjamin R Bavinton
Journal:  Sex Res Social Policy       Date:  2022-06-17

4.  PrEP user profiles, dynamics of PrEP use and follow-up: a cohort analysis at a Belgian HIV centre (2017-2020).

Authors:  Anke Rotsaert; Thijs Reyniers; Bart K M Jacobs; Thibaut Vanbaelen; Christophe Burm; Chris Kenyon; Bea Vuylsteke; Eric Florence
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

5.  Reasons for PrEP Discontinuation After Navigation at Sexual Health Clinics: Interactions Among Systemic Barriers, Behavioral Relevance, and Medication Concerns.

Authors:  Zoe D Unger; Sarit A Golub; Christine Borges; Zoe R Edelstein; Trevor Hedberg; Julie Myers
Journal:  J Acquir Immune Defic Syndr       Date:  2022-07-01       Impact factor: 3.771

6.  Who is using PrEP on-demand? Factors associated with PrEP use modality among Black and Hispanic/Latino emerging adults.

Authors:  Antonia E Caba; Taylor Rathus; Esther Burson; Philip A Chan; Lisa A Eaton; Ryan J Watson
Journal:  AIDS Behav       Date:  2022-04-19

7.  Perspectives on and preferences for on-demand and long-acting PrEP among sexual and gender minority adolescents assigned male at birth.

Authors:  Kathryn Macapagal; Mara Nery-Hurwit; Margaret Matson; Shariell Crosby; George J Greene
Journal:  Sex Res Social Policy       Date:  2020-02-21

8.  Evaluation of the 'Colli-Pee', a first-void urine collection device for self-sampling at home for the detection of sexually transmitted infections, versus a routine clinic-based urine collection in a one-to-one comparison study design: efficacy and acceptability among MSM in Belgium.

Authors:  Irith De Baetselier; Hilde Smet; Said Abdellati; Bénédicte De Deken; Vicky Cuylaerts; Thijs Reyniers; Bea Vuylsteke; Tania Crucitti
Journal:  BMJ Open       Date:  2019-04-03       Impact factor: 2.692

9.  Toward a Set of Criteria to Decide Which STIs to Screen for in PrEP Cohorts.

Authors:  Chris Kenyon
Journal:  Front Public Health       Date:  2019-06-12

10.  Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.

Authors:  Venkatesan Chakrapani; Murali Shunmugam; Shruta Rawat; Dicky Baruah; Ruban Nelson; Peter A Newman
Journal:  AIDS Patient Care STDS       Date:  2020-01-17       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.